Table 2.
Case | Diagnosis | ATM score | p53 | p63 | CK5/6 | ER | αSMA |
1 | Adenomyoepithelioma | 4 | Negative | + | + | NA | NA |
2 | Adenomyoepithelioma | 0 | Negative | NA | NA | NA | NA |
3 | Adenomyoepithelioma | 0 | NA | ++ | NA | ++ | ++ |
4 | Malignant myoepithelioma | 3 | Positive | + | + | – | + |
5 | Malignant myoepithelioma | 3 | Negative | ++ | ++ | NA | NA |
6 | Malignant myoepithelioma | 2 | Positive | ++ | ++ | – | ++ |
7 | Malignant myoepithelioma | 2 | Positive | ++ | ++ | – | ++ |
8 | Malignant myoepithelioma | 0 | Positive | ++ | ++ | – | + |
9 | Malignant myoepithelioma | 0 | Positive | – | NA | NA | NA |
10 | Malignant myoepithelioma | 0 | Negative | ++ | ++ | – | – |
11 | Malignant myoepithelioma | 0 | Negative | ++ | ++ | NA | NA |
12 | Malignant myoepithelioma | 0 | Negative | ++ | NA | NA | NA |
13 | Malignant myoepithelioma | 0 | NA | ++ | ++ | ++ | – |
14 | Matrix producing breast carcinoma | 3 | Positive | + | + | – | + |
15 | Sarcomatoid breast carcinoma | 0 | Positive | + | + | – | ++ |
16 | Sarcomatoid breast carcinoma | 0 | Negative | NA | NA | – | – |
17 | Sarcomatoid breast carcinoma | 12 | Positive | ++ | + | – | – |
18 | Sarcomatoid breast carcinoma | 0 | Negative | ++ | ++ | – | – |
+, focally positive; ++, diffusely positive; αSMA, α smooth muscle actin; ER, oestrogen receptor; NA, not available.